Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy. MedStar authors:
  • Chen, Kevin Y
  • Peravali, Monica
  • Rao, Suman
  • Veytsman, Irina
PMID:
  • 35649819
Year: 2022
Citation:
  • Clinical Lung Cancer. 2022 Apr 29
Institution:
  • MedStar Franklin Square Medical Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology/Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Chen KY, Geng X, Giaccone G, Joshi I, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
DOI:
Add to cart
2.
Pembrolizumab-Associated Cutaneous and Pulmonary Sarcoidosis in Non-Small Cell Lung Cancer Treatment. MedStar authors:
  • Cardis, Michael
  • Dewitt, Christine A
PMID:
  • 35701321
Year: 2022
Citation:
  • Clinical Lung Cancer. 23(6):542-546, 2022 09.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Dermatology
Medline publication type:
  • Case Reports
Form of publication:
  • Journal Article
All authors:
  • Cardis M, Dewitt CA, Fleury CM, Holmes M, Kim C, Krochmal R, Sirgi Y
DOI:
Add to cart
Pages

Powered by Koha